Bosh sahifaIDP • FRA
add
Biogen Inc
Yopilish kursi
111,10 €
Kunlik diapazon
110,00 € - 110,90 €
Yillik diapazon
99,82 € - 217,20 €
Bozor kapitalizatsiyasi
18,43 mlrd USD
Oʻrtacha hajm
32,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,43 mlrd | 6,13% |
Joriy xarajat | 1,17 mlrd | 0,97% |
Sof foyda | 240,50 mln | -38,87% |
Sof foyda marjasi | 9,89 | -42,43% |
Har bir ulushga tushum | 3,02 | -17,71% |
EBITDA | 865,10 mln | 10,92% |
Amaldagi soliq stavkasi | 22,72% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,60 mlrd | 141,84% |
Jami aktivlari | 28,03 mlrd | 5,52% |
Jami passivlari | 11,05 mlrd | -2,64% |
Umumiy kapital | 16,98 mlrd | — |
Tarqatilgan aksiyalar | 146,53 mln | — |
Narxi/balansdagi bahosi | 0,96 | — |
Aktivlardan daromad | 6,08% | — |
Kapitaldan daromad | 7,25% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 240,50 mln | -38,87% |
Operatsiyalardan naqd pul | 259,30 mln | -53,13% |
Sarmoyadan naqd pul | -47,30 mln | 28,33% |
Moliyadan naqd pul | -23,00 mln | 94,77% |
Naqd pulning sof oʻzgarishi | 223,30 mln | 811,43% |
Boʻsh pul | 514,39 mln | 45,68% |
Haqida
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Tashkil etilgan
1978
Sayt
Xodimlar soni
7 605
